Céline Narjoz
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Oncology 12
- Colorectal Cancer Treatments and Studies 7
- Pancreatic and Hepatic Oncology Research 4
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Philippe Beaune (8 shared papers)Marie‐Anne Loriot (22 shared papers)Isabelle de Waziers (3 shared papers)Rosette Lidereau (1 shared paper)Tarik Asselah (1 shared paper)Ivan Bièche (1 shared paper)Patrick Marcellin (1 shared paper)Laurent Chouchana (4 shared papers)
- Journals
- European Journal of Cancer (3 papers)PLoS ONE (2 papers)British Journal of Clinical Pharmacology (2 papers)Pharmacogenomics (2 papers)Pharmacogenetics and Genomics (1 paper)
- Partner nations
- FranceSwitzerlandBelgium
In The Last Decade
Céline Narjoz
41 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Pharmacology 233
- Biochemistry 79
- Oncology 270
- Transplantation 25
- Nephrology 59
Countries citing papers authored by Céline Narjoz
This map shows the geographic impact of Céline Narjoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Narjoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Narjoz more than expected).
Fields of papers citing papers by Céline Narjoz
This network shows the impact of papers produced by Céline Narjoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Narjoz. The network helps show where Céline Narjoz may publish in the future.
Co-authors
The 25 scholars most cited alongside Céline Narjoz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 264 | |
| 2 | 2011 | 127 | |
| 3 | 2016 | 109 | |
| 4 | 2015 | 87 | |
| 5 | 2012 | 86 | |
| 6 | 2016 | 49 | |
| 7 | 2014 | 44 | |
| 8 | 2014 | 40 | |
| 9 | 2014 | 39 | |
| 10 | 2020 | 37 | |
| 11 | 2017 | 37 | |
| 12 | 2014 | 28 | |
| 13 | 2022 | 22 | |
| 14 | 2022 | 18 | |
| 15 | 2014 | 17 | |
| 16 | 2022 | 15 | |
| 17 | 2019 | 14 | |
| 18 | 2021 | 12 | |
| 19 | 2021 | 12 | |
| 20 | 2018 | 11 |
About Céline Narjoz
Céline Narjoz is a scholar working on Oncology, Molecular Biology, Pharmacology, Nephrology and Pathology and Forensic Medicine, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Pharmacogenetics and Drug Metabolism (7 papers), Genetic factors in colorectal cancer (6 papers), Renal Diseases and Glomerulopathies (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Pharmacology (233 citations), Biochemistry (79 citations), Oncology (270 citations), Transplantation (25 citations) and Nephrology (59 citations). Céline Narjoz has collaborated with scholars based in France, Switzerland and Belgium. Frequent co-authors include Philippe Beaune, Marie‐Anne Loriot, Isabelle de Waziers, Rosette Lidereau, Tarik Asselah, Ivan Bièche, Patrick Marcellin, Laurent Chouchana, Sophie Vacher and Xavier Roblin. Their work appears in journals such as European Journal of Cancer, PLoS ONE, British Journal of Clinical Pharmacology, Pharmacogenomics and Pharmacogenetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.